Position in TRLV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,141,011
New position
Shares Held
522,992
first reported quarter
Ownership
0.272%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#9
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026iA Global Asset Management Inc. holds $25,098,205 across 5 Drug Manufacturers - Specialty & Generic names. TRLV ranks #3 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
341,622 | $11,574,153 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
303,786 | $5,455,996 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
This page
|
522,992 | $5,141,011 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,166 | $1,544,837 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,551 | $1,382,208 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,141,011 | 522,992 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||